283 related articles for article (PubMed ID: 1531910)
21. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
[TBL] [Abstract][Full Text] [Related]
22. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain.
Mascalchi M; Lolli F; Della Nave R; Tessa C; Petralli R; Gavazzi C; Politi LS; Macucci M; Filippi M; Piacentini S
Radiology; 2004 Sep; 232(3):867-73. PubMed ID: 15215553
[TBL] [Abstract][Full Text] [Related]
23. Variation of selective gray and white matter atrophy in Huntington's disease.
Jech R; Klempír J; Vymazal J; Zidovská J; Klempírová O; Růzicka E; Roth J
Mov Disord; 2007 Sep; 22(12):1783-9. PubMed ID: 17579363
[TBL] [Abstract][Full Text] [Related]
24. Brain structure in preclinical Huntington's disease.
Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
[TBL] [Abstract][Full Text] [Related]
25. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
26. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
27. Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry.
Raz N; Torres IJ; Acker JD
Neurobiol Learn Mem; 1995 Mar; 63(2):133-42. PubMed ID: 7663886
[TBL] [Abstract][Full Text] [Related]
28. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.
Lisanby SH; McDonald WM; Massey EW; Doraiswamy PM; Rozear M; Boyko OB; Krishnan KR; Nemeroff C
J Neural Transm Suppl; 1993; 40():13-21. PubMed ID: 8294897
[TBL] [Abstract][Full Text] [Related]
29. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.
Turner LM; Jakabek D; Wilkes FA; Croft RJ; Churchyard A; Walterfang M; Velakoulis D; Looi JC; Georgiou-Karistianis N; Apthorp D
Brain Behav; 2016 Dec; 6(12):e00511. PubMed ID: 28031992
[TBL] [Abstract][Full Text] [Related]
30. Striatal volumes in affected and unaffected relatives of bipolar patients--high-risk study.
Hajek T; Gunde E; Slaney C; Propper L; MacQueen G; Duffy A; Alda M
J Psychiatr Res; 2009 Apr; 43(7):724-9. PubMed ID: 19046588
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography of striatal serotonin transporters in Parkinson disease.
Kerenyi L; Ricaurte GA; Schretlen DJ; McCann U; Varga J; Mathews WB; Ravert HT; Dannals RF; Hilton J; Wong DF; Szabo Z
Arch Neurol; 2003 Sep; 60(9):1223-9. PubMed ID: 12975287
[TBL] [Abstract][Full Text] [Related]
32. Onset and rate of striatal atrophy in preclinical Huntington disease.
Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
[TBL] [Abstract][Full Text] [Related]
33. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
34. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
[TBL] [Abstract][Full Text] [Related]
36. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
Furukawa F; Ishikawa K; Yokota T; Sanjo N
Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
[TBL] [Abstract][Full Text] [Related]
37. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.
Aylward EH; Codori AM; Rosenblatt A; Sherr M; Brandt J; Stine OC; Barta PE; Pearlson GD; Ross CA
Mov Disord; 2000 May; 15(3):552-60. PubMed ID: 10830423
[TBL] [Abstract][Full Text] [Related]
38. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.
Vandenberghe W; Demaerel P; Dom R; Maes F
J Neurol; 2009 Jan; 256(1):109-14. PubMed ID: 19267169
[TBL] [Abstract][Full Text] [Related]
39. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.
Reading SA; Yassa MA; Bakker A; Dziorny AC; Gourley LM; Yallapragada V; Rosenblatt A; Margolis RL; Aylward EH; Brandt J; Mori S; van Zijl P; Bassett SS; Ross CA
Psychiatry Res; 2005 Oct; 140(1):55-62. PubMed ID: 16199141
[TBL] [Abstract][Full Text] [Related]
40. Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.
Misiura MB; Ciarochi J; Vaidya J; Bockholt J; Johnson HJ; Calhoun VD; Paulsen JS; Turner JA;
J Int Neuropsychol Soc; 2019 May; 25(5):462-469. PubMed ID: 30806337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
